Reaction profile

The FDA adverse-event record for application site moist eczema

29 FDA reports name application site moist eczema, a lower-volume reaction in the CVM extract (VeDDRA 2065). Plate stamps and neighbourhood peers follow.

#2010 of 2,481
by report volume (all reactions)
29
reports citing this reaction
3.4%
death-coded share
Cat
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Application site moist eczema has 29 reports now versus 29 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Application site moist eczema changes

FDA AER · VeDDRA plate

Code 2065 VOL-TRACE

VOL-TRACE · DEATH-LOW · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 29 reports
  • DEATH-LOW 3.4%
  • LOWER-Q #2010/2481
  • PHOTO-FINISH Blue eye
  • SPECIES-CAT Cat · 19
  • DRUG-LEAD Selamectin;Sarola… · 10
  • DESK-WIDE 10 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Blue eye (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Application site moist eczema

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Application site mois… · thi…29Blue eye · near29Enteric pathogen NOS · near29Generalised skin slou… · near29Lack of efficacy (bac… · near29Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Application site moist eczema

Application site moist eczema: low death-coded share in the FDA AER plate

Signature read: 1 death-coded reports is a thin tail count for Application site moist eczema in the CVM extract. Report volume is lower-third scale: 29 named reports in the openFDA extract. Death-coded share is lower-third: 1 of 29 reports (3.4% of named reports). Nearest volume peer: Blue eye (±0 reports). Lead species Cat (19). Lead co-reported drug Selamectin;Sarolaner (10).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Selamectin;Sarolaner appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 19
Dog 10

Breeds Most Affected

Domestic Shorthair 12
Crossbred Canine/dog 4
Domestic Longhair 4
Shepherd Dog - German 2
Pit Bull 2
Domestic Mediumhair 1
Retriever - Golden 1
Dog (other) 1
Cat (other) 1
Cat (unknown) 1

Associated Drugs

Selamectin;Sarolaner 10
Imidacloprid + Moxidectin 9
Emodepside + Praziquantel 3
Flumethrin-Imidacloprid 2
Afoxolaner 2
Imidacloprid, Flumethrin 2
Vaccine 1
Rabies 1
Distemper 1
Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg 1
Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On 1
Selamectin 1
Chlorhexidine + Ketoconazole + Phytosphingosine 1
Enrofloxacin 1
Oclacitinib 1
Diphenhydramine 1
Hydracortisone 1
Dexamethasone + Neomycin Sulfate + Thiabendazole 1
Praziquantel Pyrantel Pamoate 1
Imidacloprid, Moxidectin 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Application site moist eczema (#2010 of 2,481 by report volume); death-coded 3.4%. PlainBreed reaction plate · death-coded report count stamp 1 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →